Literature DB >> 24114053

Intensity of follow-up after melanoma surgery.

Christopher P Scally1, Sandra L Wong.   

Abstract

This contemporary review of melanoma surveillance strategies seeks to help practitioners examine and improve their surveillance protocols based on the currently available data. In general, there is no definitive benefit from increased screening or more aggressive use of interval imaging. Low-intensity surveillance strategies do not appear to adversely affect patient outcomes and should be the preferred approach compared with high-intensity strategies for most melanoma patients. All surveillance programs should emphasize education in order to maximize the effectiveness of patient-based detection of recurrent disease.

Entities:  

Mesh:

Year:  2013        PMID: 24114053     DOI: 10.1245/s10434-013-3295-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  A Retrospective Analysis of Surveillance Adherence of Patients after Treatment of Primary Cutaneous Melanoma.

Authors:  Jeave Reserva; Monica Janeczek; Cara Joyce; Amanda Goslawski; Hwala Hong; Feng-Ning Yuan; Neelam Balasubramanian; Laura Winterfield; James Swan; Rebecca Tung
Journal:  J Clin Aesthet Dermatol       Date:  2017-12-01

Review 2.  Usefulness of High-Frequency Ultrasonography in the Diagnosis of Melanoma: Mini Review.

Authors:  Maria Paola Belfiore; Alfonso Reginelli; Anna Russo; Gaetano Maria Russo; Maria Paola Rocco; Elvira Moscarella; Marilina Ferrante; Antonello Sica; Roberto Grassi; Salvatore Cappabianca
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

Review 3.  Follow-up in melanoma patients.

Authors:  Piotr Rutkowski; Iwona Lugowska
Journal:  Memo       Date:  2014-06-24

4.  The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.

Authors:  Samantha Damude; Josette E H M Hoekstra-Weebers; Anne Brecht Francken; Sylvia Ter Meulen; Esther Bastiaannet; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2016-05-18       Impact factor: 5.344

5.  Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.

Authors:  Idoia Ortega-Martínez; Jesús Gardeazabal; Asier Erramuzpe; Ana Sanchez-Diez; Jesús Cortés; María D García-Vázquez; Gorka Pérez-Yarza; Rosa Izu; Jose Luís Díaz-Ramón; Ildefonso M de la Fuente; Aintzane Asumendi; María D Boyano
Journal:  Int J Cancer       Date:  2016-06-11       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.